Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • bluecheese4u bluecheese4u Jan 29, 2013 8:08 AM Flag

    PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2012 RESULTS; PROVIDES 2013 FINANCIAL GUIDANCE

    PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2012 RESULTS; PROVIDES 2013 FINANCIAL GUIDANCE

     Fourth-Quarter 2012 Revenues of $15.1 Billion and Full-Year Revenues of $59.0 Billion, both
    excluding Discontinued Operations Revenues of $592 Million and $2.3 Billion, Respectively,
    from the Nutrition(1) Business
     Fourth-Quarter 2012 Adjusted Diluted EPS(2) of $0.47, Reported Diluted EPS(3) of $0.85; Full-
    Year 2012 Adjusted Diluted EPS(2) of $2.19, Reported Diluted EPS(3) of $1.94
     Repurchased $3.4 Billion and $8.2 Billion of Common Stock in Fourth-Quarter and Full-Year
    2012, Respectively
     Provides Initial 2013 Financial Guidance; Reflects the Benefit of a Full-Year Contribution from
    Zoetis(4), Partially Offset by a $0.02 Unfavorable Impact on Adjusted(2) and Reported(3) Diluted
    EPS Guidance for Zoetis(4)-Related Interest Expense and Certain Duplicative and Other Costs
    Given its Potential Separation

    pfizerDOTcom/files/investors/presentations/q4performance_012913.pdf

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • PFE Chart
      bigchartsDOTmarketwatchDOTcom/advchart/frames/framesDOTasp?show=&insttype=Stock&symb=pfe&time=6&startdate=1%2F4%2F1999&enddate=1%2F8%2F2012&freq=1&compidx=aaaaa%3A0&comptemptext=&comp=&ma=4&maval=9+15+50&uf=7168&lf=1&lf2=4&lf3=2&type=4&style=320&size=3&timeFrameToggle=false&compareToToggle=false&indicatorsToggle=false&chartStyleToggle=false&state=11&x=0&y=0

      Analyst Estimates
      marketwatchDOTcom/investing/stock/pfe/analystestimates

 
PFE
35.73-0.03(-0.08%)Jul 30 4:00 PMEDT